[HTML] thieme-connect.com

[HTML][HTML] Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge

F Violi, D Pastori, R Cangemi… - Thrombosis and …, 2020 - thieme-connect.com
The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number …
被引用次数：286 相关文章

Hypercoagulation and antithrombotic treatment in coronavirus 2019: a new challenge.

F Violi, D Pastori, R Cangemi, P Pignatelli, L Loffredo - 2020 - cabidigitallibrary.org
Abstract The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number …

Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge

F Violi, D Pastori, R Cangemi… - Thrombosis and …, 2020 - pubmed.ncbi.nlm.nih.gov
The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number …

Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge.

F Violi, D Pastori, R Cangemi, P Pignatelli… - Thrombosis and …, 2020 - europepmc.org
Abstract The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number …
[PDF] sah.org.ar

[PDF][PDF] Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge

F Violi, D Pastori, R Cangemi, P Pignatelli, L Loffredo - 2020 - sah.org.ar
Abstract The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number …

Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge

F Violi, D Pastori, R Cangemi, P Pignatelli… - Thrombosis and …, 2020 - cir.nii.ac.jp
抄録< jats: title> Abstract</jats: title>< jats: p> The novel coronavirus 2019 (COVID-19) is
clinically characterized by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …
[PDF] core.ac.uk

[PDF][PDF] Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge

F Violi, D Pastori, R Cangemi, P Pignatelli, L Loffredo - 2020 - core.ac.uk
Abstract The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number …

Hypercoagulation and antithrombotic treatment in coronavirus 2019. a new challenge

F Violi, D Pastori, R Cangemi, P Pignatelli… - THROMBOSIS AND …, 2020 - iris.uniroma1.it
Abstract The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number …
[PDF] sah.org.ar

[PDF][PDF] Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge

F Violi, D Pastori, R Cangemi, P Pignatelli, L Loffredo - 2020 - sah.org.ar
Abstract The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number …
[HTML] nih.gov

[HTML][HTML] Hypercoagulation and Antithrombotic Treatment in Coronavirus 2019: A New Challenge

F Violi, D Pastori, R Cangemi, P Pignatelli… - Thrombosis and …, 2020 - ncbi.nlm.nih.gov
Abstract The novel coronavirus 2019 (COVID-19) is clinically characterized by severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), which is responsible for a high number …